Skyclarys

As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches
Fierce Pharma
Wed, 11/8/23 - 12:10 pm
Biogen
Pharma CEOs
Chris Viehbacher
earnings
Leqembi
Skyclarys
How Biogen outbid a rival 'large-cap' pharma to claim Reata for $7.3B
Fierce Pharma
Tue, 08/15/23 - 11:53 am
Biogen
Reata Pharmaceuticals
M&A
Skyclarys
Friedreich’s ataxia
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Motley Fool
Thu, 08/10/23 - 09:57 am
Biogen
Reata Pharmaceuticals
M&A
Skyclarys